CI_MoA CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult used to treat disease Norepinephrine Uptake Inhibitors [MoA] Serotonin Uptake Inhibitors [MoA] Monoamine Oxidase Inhibitors [MoA] Depressive Disorder [Disease/Finding] Drug Hypersensitivity [Disease/Finding] Myocardial Infarction [Disease/Finding] Protriptyline [Chemical/Ingredient] Decreased Serotonin Degradation [PE] Increased Central Nervous System Norepinephrine Activity [PE] P [Preparations] PROTRIPTYLINE http://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=700abc58-9362-4ef5-9d7a-dd3c4d364d0a&type=display <VANDF_Record>50.6^271^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>271</VA_IEN> 4019918 N0000148003 C0033743 PROTRIPTYLINE Active 8886 Protriptyline C19318 Ingredient <VANDF_Record>50.416^2543^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>2543</VA_IEN> 4NDU154T12 mental depression agranulocytosis AE fever AE confusion AE jaundice AE seizure AE nausea AE vomiting AE erectile dysfunction AE